Inspira Technologies Releases New Data on Core Technology

Ticker: IINNW · Form: 6-K · Filed: Mar 12, 2024 · CIK: 1837493

Sentiment: neutral

Topics: medical-technology, data-release, press-release

TL;DR

Inspira Tech drops new data showing their tech is better on HMSS Indicator endpoints.

AI Summary

On March 12, 2024, Inspira Technologies Oxy B.H.N. Ltd. issued a press release announcing new data that demonstrates the superiority of its core technology. The data focuses on key endpoints of the HMSS Indicator, suggesting improved performance and effectiveness of their medical devices.

Why It Matters

This new data could validate the effectiveness of Inspira's technology, potentially leading to increased adoption and market share in the surgical and medical instruments sector.

Risk Assessment

Risk Level: medium — The filing reports new data, which is positive, but doesn't include specific financial figures or significant strategic changes that would indicate a low risk level.

Key Players & Entities

FAQ

What specific "key endpoints" of the HMSS Indicator were improved according to the new data?

The filing states that new data demonstrates superiority across key endpoints of the HMSS Indicator, but does not specify which endpoints were improved in this summary.

When was the press release containing this new data issued?

The press release was issued on March 12, 2024.

What is the primary business of Inspira Technologies Oxy B.H.N. Ltd.?

Inspira Technologies Oxy B.H.N. Ltd. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

Is this filing an annual report?

No, this is a Form 6-K, which is a Report of Foreign Private Issuer, not an annual report (which would be Form 20-F or 40-F).

Where is Inspira Technologies Oxy B.H.N. Ltd. headquartered?

The company's principal executive office is located at 2 Ha-Tidhar St., Ra'anana 4366504, Israel.

Filing Stats: 304 words · 1 min read · ~1 pages · Grade level 8.9 · Accepted 2024-03-12 16:01:04

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: March 12, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing